BioSpace News Archive

Expanded Capabilities of VISERA ELITE II Surgical Imaging Platform May Help Reduce Costs and Improve Efficiency for Hospitals and Surgery Centers

ERT, a global leader in clinical end-point data solutions, today announced that Bioclinica, a technological and scientific leader in clinical imaging, has agreed to merge with ERT

Millions of Canadians are doing their part to help prevent the spread of COVID-19 by downloading and using the COVID Alert app.

Adial Pharmaceuticals, Inc. a clinical-stage biopharmaceutical company focused on the development of treatments for addictions, today announced that it has entered into a definitive agreement to acquire Purnovate, LLC a pharmaceutical development company focused on novel, drug candidates for non-opioid pain reduction

US Radiology Specialists, one of the premier physician-owned radiology groups in the country, announced today it has acquired ImageSouth, the largest outpatient imaging provider in Birmingham, Alabama

The Industrial Technology Research Institute, Taiwan’s largest and one of the world’s leading high-tech applied research institutions, invites you to its event site for CES 2021 to view its innovations in artificial intelligence, robotics and e-health.

New executive position will lead clinical team and oversee execution of remote delivery of industry-leading cancer support services

- For nearly 11 months, we have all been learning to live and function in a state of uncertainty, adjusting to a “new normal” as the COVID-19 pandemic has drastically affected the way most of us live, and has also tragically claimed

PhageNova Bio, Inc. (“PhageNova”) is pleased to announce the publication of data generated through a sponsored research agreement with Rutgers , The State University of New Jersey . The Med (a Cell Press publication) article, entitled Targeted Phage Display-Based Pulmonary Vaccination in Mice and Non-human Primates , describes a

Emmaus Life Sciences, Inc., a leader in the treatment of sickle cell disease, announced that it was notified by the Michigan Department of Health and Human Services that the prior authorization criteria for Endari® was revised after being reviewed by Michigan’s Medicaid Health Plan Common Formulary Workgroup.